Sarepta Therapeutics, Inc. (SRPT)
21.18
-1.05
(-4.72%)
USD |
NASDAQ |
Apr 10, 16:00
21.19
+0.01
(+0.05%)
After-Hours: 20:00
Sarepta Therapeutics EPS Diluted (Quarterly) : -3.934 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Keros Therapeutics, Inc. | -0.8626 |
| Merck & Co., Inc. | 1.191 |
| PTC Therapeutics, Inc. | -1.673 |
| Gilead Sciences, Inc. | 1.742 |
| REGENXBIO, Inc. | -1.298 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -412.23M |
| Revenue (Quarterly) | 442.93M |
| Total Expenses (Quarterly) | 855.16M |
| Enterprise Value | 2.324B |
| Gross Profit Margin (Quarterly) | 7.70% |
| Profit Margin (Quarterly) | -93.07% |
| Earnings Yield | -39.84% |
| Normalized Earnings Yield | -33.59 |